The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)June 29, 2026 — Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.
June 29, 2026 — Disseminated on behalf of Lahontan Gold Corp. (TSX.
June 29, 2026 — Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.
June 29, 2026 — Suntex Enterprises (OTC: SNTX) announced the appointment of Vincent Ornelas as an independent director, adding more than a decade of executive technology experience to its board as the company advances its long-term strategy of building a diversified operating business. Ornelas spent nearly 11 years in executive technology roles at SpaceX, supporting leadership during the company’s expansion, including early Starbase development and technology infrastructure for Starlink and xAI initiatives, and currently serves as an executive support engineer at Citadel.
June 29, 2026 — Cardio Diagnostics has positioned the science of epigenetics at the center of its diagnostic platform. Looking at an individual person’s epigenetics can provide invaluable insight into the impact of their lifestyle, behavior, and environment.
June 29, 2026 — Oncotelic Therapeutics (OTCQB: OTLC), together with Sapu Nano, announced the publication of a peer-reviewed manuscript in the International Journal of Molecular Sciences validating its proprietary Deciparticle(TM) nanoparticle platform through the development of Sapu003, an investigational intravenous everolimus formulation currently being evaluated in an ongoing Phase 1b clinical trial. The publication details the platform’s formulation design, scalable cGMP manufacturing process, product stability and preclinical performance, while demonstrating its potential to enable intravenous delivery of poorly water-soluble therapeutic compounds.
June 29, 2026 — Swarmer (NASDAQ: SWMR) announced an amendment to its May 2026 software licensing agreement that increases the total contract value to $3. 87 million and is expected to generate an additional $1.
June 29, 2026 — Oracle has reduced its global workforce by about 21,000 employees as the company moves more aggressively into artificial intelligence and cloud technology. The decision marks one of the largest workforce reductions in Oracle’s history and reflects the growing impact that AI is having on the technology industry.
June 29, 2026 — Refined copper has enjoyed record prices, but the facilities that smelt the concentrate are struggling to stay afloat because processing fees have tanked to extremely low levels. Processors now have to depend on the by-products of the refining process in order to keep their doors open.
June 29, 2026 — AINewsWire Editorial Coverage: A tectonic shift is reshaping global semiconductor manufacturing. Hundreds of billions of dollars in new investment are flowing into the United States, pulling Taiwan’s advanced manufacturing ecosystem closer to North American customers, capital markets and emerging opportunities.
June 29, 2026 — Quantum computing advancement has become a defining priority for American national security and technological competitiveness. The Trump administration released executive orders addressing two interconnected objectives: accelerating domestic quantum research and protecting federal computing infrastructure from emerging threats.
June 29, 2026 — Nightfood Holdings (OTCQB: NGTF), through its TechForce Robotics subsidiary, is positioning itself to capitalize on the ongoing migration of Taiwan’s semiconductor supply chain to the United States through a strategic alliance with Taiwan-based Jiun Jiang Enterprise Co. Ltd.
June 29, 2026 — SS Innovations reported record first-quarter 2026 revenue of $11. 1 million, up 116.
June 29, 2026 — This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising. Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) reported fiscal 2026 financial results and provided an update on its clinical pipeline, highlighting continued progress of its lead candidate HLP003 for major depressive disorder.
June 29, 2026 — This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.
June 29, 2026 — Tonix Pharmaceuticals (NASDAQ: TNXP) announced the first patient has been enrolled in the HORIZON Phase 2 trial evaluating TNX-102 SL 5. 6 mg as a first-line monotherapy for adults with major depressive disorder (MDD).
June 29, 2026 — This article has been disseminated on behalf of G Mining Ventures Corp. and may include paid advertising.
June 29, 2026 — HealthLynked (OTCQB: HLYK) announced the launch of its next-generation AI Agent Platform, a conversational voice AI solution designed to automate patient scheduling, care coordination and healthcare communications for both patients and providers. The platform supports inbound and outbound voice interactions, enabling AI agents to schedule appointments, navigate physician office phone systems, collect patient and insurance information, perform intake functions, confirm appointments and provide 24/7 answering services for healthcare practices.
June 29, 2026 — Xlife Sciences (SIX: XLS) announced that shareholders approved all proposals presented at the company’s Annual General Meeting, where 3,134,367 voting shares, representing 54. 3% of the total share capital, were represented.
June 29, 2026 — This article has been disseminated on behalf of Redwood AI Corp. and may include paid advertising.